{"transactions":[{"id":839400,"issuer":{"id":2291,"kind":"organization","name":"Rush Street Interactive, Inc.","symbol":"RSI"},"owners":[{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":1,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-17T18:24:36.000Z","date":"2026-03-14","kind":"grant","planned":false,"acquired":true,"shares":7968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"On March 14, 2026, the Reporting Person was awarded 7,968 restricted stock units (the \"RSUs\") under the Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan, as amended. The RSUs vest as of the Issuer's next annual meeting of stockholders to be held in calendar year 2027."}],"balance_after":20789,"source":{"system":"sec-edgar","filing":"0001083033-26-000002","document":"wk-form4_1773786274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000108303326000002/wk-form4_1773786274.xml","form_type":"4"}},{"id":1131003,"issuer":{"id":2291,"kind":"organization","name":"Rush Street Interactive, Inc.","symbol":"RSI"},"owners":[{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":1,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-29T17:54:27.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":10958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"On May 29, 2025, the Reporting Person was awarded 10,958 restricted stock units (the \"RSUs\") under the Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan, as amended. The RSUs vest as of the Issuer's next annual meeting of stockholders to be held in calendar year 2026."}],"balance_after":12821,"source":{"system":"sec-edgar","filing":"0001793659-25-000126","document":"wk-form4_1748555661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000179365925000126/wk-form4_1748555661.xml","form_type":"4"}},{"id":1196068,"issuer":{"id":2291,"kind":"organization","name":"Rush Street Interactive, Inc.","symbol":"RSI"},"owners":[{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":1,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-20T17:56:14.000Z","date":"2025-03-19","kind":"grant","planned":false,"acquired":true,"shares":1863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 19, 2025, the Reporting Person was awarded 1,863 restricted stock units (the \"RSUs\") under the Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan, as amended. The RSUs vest as of the Issuer's next annual meeting of stockholders to be held in calendar year 2026."}],"balance_after":1863,"source":{"system":"sec-edgar","filing":"0001793659-25-000076","document":"wk-form4_1742507768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000179365925000076/wk-form4_1742507768.xml","form_type":"4"}},{"id":3795168,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":163122,"kind":"organization","name":"Delaware Street Capital Master Fund, L.P.","position":1,"cik":"0001648576","reported_name":"Delaware Street Capital Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104447,"kind":"organization","name":"DSC Advisors, L.P.","position":2,"cik":"0001299434","reported_name":"DSC Advisors, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163123,"kind":"organization","name":"DSC Managers, L.L.C.","position":3,"cik":"0001648612","reported_name":"DSC Managers, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163124,"kind":"organization","name":"DSC Advisors, L.L.C.","position":4,"cik":"0001648574","reported_name":"DSC Advisors, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":5,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2018-10-09T16:01:27.000Z","date":"2018-10-05","kind":"purchase","acquired":true,"shares":2000000,"price":3,"value":6000000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. (\"DSCA), the investment manager of Delaware Street Master Fund, L.P. (the \"Fund\"), DSC Managers, L.L.C. (\"DSCM\"), the general partner of the Fund, DSC Advisors, L.L.C. (\"DSCA LLC\"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the \"Common Stock\"), of KemPharm, Inc. (the \"Issuer\") purchased by the Fund.  Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Fund holds the shares of Common Stock directly.  DSCA serves as the investment manager to the Fund.  DSCA LLC serves as the general partner of DSCA.  DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund.  Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities."}],"balance_after":4095914,"source":{"system":"sec-edgar","filing":"0000899243-18-026415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000089924318026415/doc4.xml","form_type":"4"}},{"id":3857081,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":163122,"kind":"organization","name":"Delaware Street Capital Master Fund, L.P.","position":1,"cik":"0001648576","reported_name":"Delaware Street Capital Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104447,"kind":"organization","name":"DSC Advisors, L.P.","position":2,"cik":"0001299434","reported_name":"DSC Advisors, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163123,"kind":"organization","name":"DSC Managers, L.L.C.","position":3,"cik":"0001648612","reported_name":"DSC Managers, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163124,"kind":"organization","name":"DSC Advisors, L.L.C.","position":4,"cik":"0001648574","reported_name":"DSC Advisors, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":5,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2018-08-01T16:05:54.000Z","date":"2018-07-30","kind":"purchase","acquired":true,"shares":304283,"price":4,"value":1217132.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. (\"DSCA), the investment manager of Delaware Street Master Fund, L.P. (the \"Fund\"), DSC Managers, L.L.C. (\"DSCM\"), the general partner of the Fund, DSC Advisors, L.L.C. (\"DSCA LLC\"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the \"Common Stock\"), of KemPharm, Inc. (the \"Issuer\") purchased by the Fund.  Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Fund holds the shares of Common Stock directly.  DSCA serves as the investment manager to the Fund.  DSCA LLC serves as the general partner of DSCA.  DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund.  Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities."}],"balance_after":2095914,"source":{"system":"sec-edgar","filing":"0000899243-18-020957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000089924318020957/doc4.xml","form_type":"4"}},{"id":4208595,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":163122,"kind":"organization","name":"Delaware Street Capital Master Fund, L.P.","position":1,"cik":"0001648576","reported_name":"Delaware Street Capital Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104447,"kind":"organization","name":"DSC Advisors, L.P.","position":2,"cik":"0001299434","reported_name":"DSC Advisors, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163123,"kind":"organization","name":"DSC Managers, L.L.C.","position":3,"cik":"0001648612","reported_name":"DSC Managers, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163124,"kind":"organization","name":"DSC Advisors, L.L.C.","position":4,"cik":"0001648574","reported_name":"DSC Advisors, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":5,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-09-15T13:30:26.000Z","date":"2017-09-14","kind":"purchase","acquired":true,"shares":138857,"price":3.3027,"value":458603.0139,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The purchase price represents a weighted average of the purchase price for multiple transactions on the same trading day.  The range of purchase prices was $3.25 to $3.35.  The Reporting Persons will provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. (\"DSCA), the investment manager of Delaware Street Master Fund, L.P. (the \"Fund\"), DSC Managers, L.L.C. (\"DSCM\"), the general partner of the Fund, DSC Advisors, L.L.C. (\"DSCA LLC\"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the \"Common Stock\"), of KemPharm, Inc. (the \"Issuer\") purchased by the Fund.  Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Fund holds the shares of Common Stock directly.  DSCA serves as the investment manager to the Fund.  DSCA LLC serves as the general partner of DSCA.  DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund.  Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities."}],"balance_after":1791631,"source":{"system":"sec-edgar","filing":"0000899243-17-022122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000089924317022122/doc4.xml","form_type":"4"}},{"id":4208594,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":163122,"kind":"organization","name":"Delaware Street Capital Master Fund, L.P.","position":1,"cik":"0001648576","reported_name":"Delaware Street Capital Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104447,"kind":"organization","name":"DSC Advisors, L.P.","position":2,"cik":"0001299434","reported_name":"DSC Advisors, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163123,"kind":"organization","name":"DSC Managers, L.L.C.","position":3,"cik":"0001648612","reported_name":"DSC Managers, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163124,"kind":"organization","name":"DSC Advisors, L.L.C.","position":4,"cik":"0001648574","reported_name":"DSC Advisors, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":5,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-09-15T13:30:26.000Z","date":"2017-09-13","kind":"purchase","acquired":true,"shares":200,"price":3.25,"value":650.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. (\"DSCA), the investment manager of Delaware Street Master Fund, L.P. (the \"Fund\"), DSC Managers, L.L.C. (\"DSCM\"), the general partner of the Fund, DSC Advisors, L.L.C. (\"DSCA LLC\"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the \"Common Stock\"), of KemPharm, Inc. (the \"Issuer\") purchased by the Fund.  Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Fund holds the shares of Common Stock directly.  DSCA serves as the investment manager to the Fund.  DSCA LLC serves as the general partner of DSCA.  DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund.  Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities."}],"balance_after":1652774,"source":{"system":"sec-edgar","filing":"0000899243-17-022122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000089924317022122/doc4.xml","form_type":"4"}},{"id":4208593,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":163122,"kind":"organization","name":"Delaware Street Capital Master Fund, L.P.","position":1,"cik":"0001648576","reported_name":"Delaware Street Capital Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104447,"kind":"organization","name":"DSC Advisors, L.P.","position":2,"cik":"0001299434","reported_name":"DSC Advisors, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163123,"kind":"organization","name":"DSC Managers, L.L.C.","position":3,"cik":"0001648612","reported_name":"DSC Managers, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163124,"kind":"organization","name":"DSC Advisors, L.L.C.","position":4,"cik":"0001648574","reported_name":"DSC Advisors, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":60208,"kind":"person","name":"BLUHM ANDREW G","position":5,"cik":"0001083033","reported_name":"BLUHM ANDREW G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-09-15T13:30:26.000Z","date":"2017-09-13","kind":"purchase","acquired":true,"shares":186831,"price":3.252,"value":607574.412,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The purchase price represents a weighted average of the purchase price for multiple transactions on the same trading day.  The range of purchase prices was $3.15 to $3.30.  The Reporting Persons will provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. (\"DSCA), the investment manager of Delaware Street Master Fund, L.P. (the \"Fund\"), DSC Managers, L.L.C. (\"DSCM\"), the general partner of the Fund, DSC Advisors, L.L.C. (\"DSCA LLC\"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the \"Common Stock\"), of KemPharm, Inc. (the \"Issuer\") purchased by the Fund.  Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Fund holds the shares of Common Stock directly.  DSCA serves as the investment manager to the Fund.  DSCA LLC serves as the general partner of DSCA.  DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund.  Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities."}],"balance_after":1652574,"source":{"system":"sec-edgar","filing":"0000899243-17-022122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083033/000089924317022122/doc4.xml","form_type":"4"}}]}